Geode Capital Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
|
|||||
|
2025
Q1 | $1.48M | Buy |
|
|||||
|
2024
Q4 | $948K | Buy |
|
|||||
|
2024
Q3 | $311K | Buy |
|
|||||
|
2024
Q2 | $292K | Buy |
|
|||||
|
2024
Q1 | $333K | Buy |
|
|||||
|
2023
Q4 | $147K | Hold |
|
|||||
|
2023
Q3 | $131K | Sell |
|
|||||
|
2023
Q2 | $199K | Hold |
|
|||||
|
2023
Q1 | $259K | Hold |
|
|||||
|
2022
Q4 | $223K | Sell |
|
|||||
|
2022
Q3 | $247K | Hold |
|
|||||
|
2022
Q2 | $245K | Buy |
|
|||||
|
2022
Q1 | $418K | Buy |
|
|||||
|
2021
Q4 | $533K | Hold |
|
|||||
|
2021
Q3 | $546K | Sell |
|
|||||
|
2021
Q2 | $808K | Sell |
|
|||||
|
2021
Q1 | $1.75M | Buy |
|
|||||
|
2020
Q4 | $2.54M | Buy |
|
|||||
|
2020
Q3 | $341K | Buy |
|
|||||
|
2020
Q2 | $511K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $63K | Hold |
|
|||||
|
2019
Q3 | $40K | Hold |
|
|||||
|
2019
Q2 | $64K | Buy |
|
|||||
|
2019
Q1 | $16K | Hold |
|
|||||
|
2018
Q4 | $73K | Hold |
|
|||||
|
2018
Q3 | $63K | Hold |
|
|||||
|
2018
Q2 | $79K | Hold |
|
|||||
|
2018
Q1 | $80K | Hold |
|
|||||
|
2017
Q4 | $61K | Sell |
|
|||||
|
2017
Q3 | $69K | Hold |
|
|||||
|
2017
Q2 | $53K | Sell |
|
|||||
|
2017
Q1 | $66K | Buy |
|
|||||
|
2016
Q4 | $71K | Buy |
|
|||||
|
2016
Q3 | $347K | Buy |
|
|||||
|
2016
Q2 | $298K | Sell |
|
|||||
|
2016
Q1 | $351 | Buy |
|
|||||
|
2015
Q4 | $662K | Buy |
|
|||||
|
2015
Q3 | $579K | Buy |
|
|||||
|
2015
Q2 | $723K | Buy |
|
|||||
|
2015
Q1 | $266K | Buy |
|
|||||
|
2014
Q4 | $114K | Buy |
|